Literature DB >> 24516507

Immune aspects of the breast tumor microenvironment.

Akhil Chawla1, Gheath Alatrash2, Yun Wu3, Elizabeth A Mittendorf1.   

Abstract

The immune response in the tumor microenvironment is complex, consisting of cells from both the adaptive and innate immune systems. The phenotype and function of these cells are dictated by cytokines present in the microenvironment, as well as by the interactions of these cells with the tumor cells and each other. Technological advances have allowed investigators to better identify the specific immune cells present and immune-related gene signatures overexpressed in the tumor microenvironment. Increased knowledge of tumor immunology has allowed us to better understand how these cells and the developing tumor interact. Together, these advances have prompted the conduct of numerous studies investigating the prognostic and predictive significance of immune infiltrates.

Entities:  

Year:  2013        PMID: 24516507      PMCID: PMC3917569          DOI: 10.2217/bmt.13.15

Source DB:  PubMed          Journal:  Breast Cancer Manag        ISSN: 1758-1923


  79 in total

Review 1.  The role of the tumour inflammatory cell infiltrate in predicting recurrence and survival in patients with primary operable breast cancer.

Authors:  Zahra M A Mohammed; James J Going; Joanne Edwards; Donald C McMillan
Journal:  Cancer Treat Rev       Date:  2012-05-30       Impact factor: 12.111

2.  Immune-mediated eradication of tumors through the blockade of transforming growth factor-beta signaling in T cells.

Authors:  L Gorelik; R A Flavell
Journal:  Nat Med       Date:  2001-10       Impact factor: 53.440

3.  CD91-dependent programming of T-helper cell responses following heat shock protein immunization.

Authors:  Sudesh Pawaria; Robert J Binder
Journal:  Nat Commun       Date:  2011-11-01       Impact factor: 14.919

4.  FcγR2A and 3A polymorphisms predict clinical outcome of trastuzumab in both neoadjuvant and metastatic settings in patients with HER2-positive breast cancer.

Authors:  K Tamura; C Shimizu; T Hojo; S Akashi-Tanaka; T Kinoshita; K Yonemori; T Kouno; N Katsumata; M Ando; K Aogi; F Koizumi; K Nishio; Y Fujiwara
Journal:  Ann Oncol       Date:  2010-11-25       Impact factor: 32.976

Review 5.  The regulation of Foxp3 expression in regulatory CD4(+)CD25(+)T cells: multiple pathways on the road.

Authors:  Lianjun Zhang; Yong Zhao
Journal:  J Cell Physiol       Date:  2007-06       Impact factor: 6.384

Review 6.  Immune infiltration in human tumors: a prognostic factor that should not be ignored.

Authors:  F Pagès; J Galon; M-C Dieu-Nosjean; E Tartour; C Sautès-Fridman; W-H Fridman
Journal:  Oncogene       Date:  2009-11-30       Impact factor: 9.867

7.  FOXP3+ regulatory T cells affect the development and progression of hepatocarcinogenesis.

Authors:  Noritoshi Kobayashi; Nobuyoshi Hiraoka; Wataru Yamagami; Hidenori Ojima; Yae Kanai; Tomoo Kosuge; Atsushi Nakajima; Setsuo Hirohashi
Journal:  Clin Cancer Res       Date:  2007-02-01       Impact factor: 12.531

8.  Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy.

Authors:  Lionel Apetoh; François Ghiringhelli; Antoine Tesniere; Michel Obeid; Carla Ortiz; Alfredo Criollo; Grégoire Mignot; M Chiara Maiuri; Evelyn Ullrich; Patrick Saulnier; Huan Yang; Sebastian Amigorena; Bernard Ryffel; Franck J Barrat; Paul Saftig; Francis Levi; Rosette Lidereau; Catherine Nogues; Jean-Paul Mira; Agnès Chompret; Virginie Joulin; Françoise Clavel-Chapelon; Jean Bourhis; Fabrice André; Suzette Delaloge; Thomas Tursz; Guido Kroemer; Laurence Zitvogel
Journal:  Nat Med       Date:  2007-08-19       Impact factor: 53.440

Review 9.  The tumor microenvironment and its role in promoting tumor growth.

Authors:  T L Whiteside
Journal:  Oncogene       Date:  2008-10-06       Impact factor: 9.867

10.  Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells.

Authors:  H Groux; M Bigler; J E de Vries; M G Roncarolo
Journal:  J Exp Med       Date:  1996-07-01       Impact factor: 14.307

View more
  6 in total

1.  Cancer Stem Cells in the Immune Microenvironment.

Authors:  Dong-Sup Lee; Keunhee Oh
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  Breast cancer circulating biomarkers: advantages, drawbacks, and new insights.

Authors:  Andrea Ravelli; James M Reuben; Francesco Lanza; Simone Anfossi; Maria Rosa Cappelletti; Laura Zanotti; Angela Gobbi; Chiara Senti; Paola Brambilla; Manuela Milani; Daniele Spada; Paolo Pedrazzoli; Massimo Martino; Alberto Bottini; Daniele Generali
Journal:  Tumour Biol       Date:  2015-08-26

3.  Inhibition of tumor progression during allergic airway inflammation in a murine model: significant role of TGF-β.

Authors:  Belen Tirado-Rodriguez; Guillermina Baay-Guzman; Rogelio Hernandez-Pando; Gabriela Antonio-Andres; Mario I Vega; Leticia Rocha-Zavaleta; Laura C Bonifaz; Sara Huerta-Yepez
Journal:  Cancer Immunol Immunother       Date:  2015-06-16       Impact factor: 6.968

4.  Overexpression of syndecan-1, MUC-1, and putative stem cell markers in breast cancer leptomeningeal metastasis: a cerebrospinal fluid flow cytometry study.

Authors:  Iole Cordone; Serena Masi; Valentina Summa; Mariantonia Carosi; Antonello Vidiri; Alessandra Fabi; Alessia Pasquale; Laura Conti; Immacolata Rosito; Carmine Maria Carapella; Veronica Villani; Andrea Pace
Journal:  Breast Cancer Res       Date:  2017-04-11       Impact factor: 6.466

5.  STAT3 Silencing and TLR7/8 Pathway Activation Repolarize and Suppress Myeloid-Derived Suppressor Cells From Breast Cancer Patients.

Authors:  Elham Safarzadeh; Ali Mohammadi; Behzad Mansoori; Pascal H G Duijf; Shahryar Hashemzadeh; Vahid Khaze; Tohid Kazemi; Afshin Derakhshani; Nicola Silvestris; Behzad Baradaran
Journal:  Front Immunol       Date:  2021-02-19       Impact factor: 7.561

6.  Major Differences in Lymphocyte Subpopulations Between Cerebrospinal Fluid and Peripheral Blood in Non-Hodgkin Lymphoma Without Leptomeningeal Involvement: Flow Cytometry Evidence of a Cerebral Lymphatic System.

Authors:  Iole Cordone; Serena Masi; Diana Giannarelli; Alessia Pasquale; Laura Conti; Stefano Telera; Andrea Pace; Elena Papa; Mirella Marino; Paolo de Fabritiis; Andrea Mengarelli
Journal:  Front Oncol       Date:  2021-06-03       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.